Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹2,109.70
  • Day's High
  • ₹2,135.10
₹ 2,115.50
  • 52-w low
  • ₹1,131.70
  • 52-w high
  • ₹2,353.95
2,115.50
  • Day's open
    ₹2,135.10
  • Previous close
    ₹2,124.45
  • VWAP
    ₹2,118.54
  • Lower price band
    ₹1,699.60
  • Upper price band
    ₹2,549.30

Today's Market Action

The last traded share price of Ajanta Pharma Ltd was 2,115.50 down by -0.42% on the NSE. Its last traded stock price on BSE was 2,119.90 down by -0.21%. The total volume of shares on NSE and BSE combined was 3,722 shares. Its total combined turnover was Rs 0.79 crores.

Medium and Long Term Market Action

Ajanta Pharma Ltd hit a 52-week high of 2,353.95 on 04-01-2024 and a 52-week low of 1,131.70 on 24-03-2023. The stock price of Ajanta Pharma Ltd is down by -1% over the last one month. It is up by 80.04% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 26750

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Ajanta Pharma Ltd?

What is the Market Cap of Ajanta Pharma Ltd?

What is PE Ratio of Ajanta Pharma Ltd?

What is PB Ratio of Ajanta Pharma Ltd?

What is the CAGR of Ajanta Pharma Ltd?

How to Buy Ajanta Pharma Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 89.80% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
  • High Pricing Power
    The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.01. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
  • High Shareholder Pedigree
    The company has a solid long term shareholder base which reduces the degree of speculation and volatility in the stock. This works well for long term equity shareholders.

Cons

  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 174 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 12% of the total company's shareholding which can have a significantly negative impact on stock.

Valuation Analysis

Margin of safety
(19/03/2024)
Stock Valuation
Green line
92
100.00%
100.00% People are bullish about Ajanta Pharma Ltd
0.00%
0.00 % People are bearish about Ajanta Pharma Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Ajanta Pharma Ltd

2,115.50 -8.95 (-0.42%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %